MET and breast carcinoma: The inhibition of mammary cancer cell growth was associated with the ability of HVS to disrupt c-Met receptor phosphorylation in response to its natural ligand HGF in MDA-MB-231, MCF-7, and BT474 breast cancer cells (Figure 7A) and inhibit the downstream c-Met effectors in culture (Figure 8).